Clinical Trials Logo

Clinical Trial Summary

This study will evaluate thrombogenicity in patients undergoing left atrial appendage closure using the WATCHMAN device. Parameters of thrombosis and platelet function, as well as other bio-markers, will be measure before, during, and after WATCHMAN implantation at several follow up visits.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03040622
Study type Observational
Source Inova Health Care Services
Contact
Status Completed
Phase
Start date March 1, 2017
Completion date December 31, 2019

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06293430 - Registry on Luma Vision's VERAFEYE System (ENLIgHT)
Recruiting NCT03568890 - Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure Phase 4
Recruiting NCT03014557 - China REgistry of WATCHMAN N/A
Recruiting NCT03409159 - Austrian Left Atrial Appendage Closure Registry
Recruiting NCT03088072 - A Pilot Study of Edoxaban in Patients With Non-Valvular Atrial Fibrillation and Left Atrial Appendage Closure Phase 4
Withdrawn NCT02309268 - Atrial Appendage Closure Prospective Observational Study N/A
Active, not recruiting NCT03399851 - Comparison of Amplatzer Amulet and Watchman Device in Patients Undergoing Left Atrial Appendage Closure. (SWISS-APERO) N/A
Recruiting NCT05743322 - The Usefulness of Biatrial 3D Printing to Plan Transseptal Puncture for the Left Atrial Appendage Closure N/A
Active, not recruiting NCT06348394 - Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion N/A
Not yet recruiting NCT05931835 - Feasibility Study on the VERAFEYE System N/A
Completed NCT03147391 - Left Atrial Appendage Closure With the LAmbre N/A